Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Endocannabinoids and liver disease III Endocannabinoid effects on immune cells: implications for inflammatory liver diseases Pacher P; Gao BAm J Physiol Gastrointest Liver Physiol 2008[Apr]; 294 (4): G850-4Recent studies have implicated dysregulation of the endocannabinoid system in various liver diseases and their complications (e.g., hepatitis, fibrosis, cirrhosis, cirrhotic cardiomyopathy, and ischemia-reperfusion), and demonstrated that its modulation by either cannabinoid 2 (CB(2)) receptor agonists or CB(1) antagonists may be of significant therapeutic benefits. This review is aimed to focus on the triggers and sources of endocannabinoids during liver inflammation and on the novel role of CB(2) receptors in the interplay between the activated endothelium and various inflammatory cells (leukocytes, lymphocytes, etc.), which play pivotal role in the early development and progression of inflammatory and other liver diseases.|*Endocannabinoids[MESH]|Animals[MESH]|Cannabinoid Receptor Modulators/*metabolism[MESH]|Endothelium, Vascular/immunology/metabolism[MESH]|Hepatitis/immunology/*metabolism[MESH]|Humans[MESH]|Leukocytes/*metabolism[MESH]|Liver Cirrhosis/immunology/metabolism[MESH]|Liver/immunology/*metabolism[MESH]|Receptors, Cannabinoid/metabolism[MESH]|Reperfusion Injury/immunology/metabolism[MESH] |